Montelukast Description and Brand Names

Montelukast is indicated in the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled

Montelukast is a selective leukotriene receptor antagonist that has been shown to be effective in the treatment of chronic asthma

mg slot Adverse events were comparable No patients using montelukast were thought to have had a drug-related adverse event Montelukast has been compared

slot auto wallet 10รับ100 Dosing · Adults and children 15 years of age and older—10 milligrams once a day, taken in the morning or evening · Children younger than 15